Beyond amyloid: A roadmap for integrated, multi-target Alzheimer’s therapy
Peer-Reviewed Publication
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Updates every hour. Last Updated: 21-Jun-2026 18:15 ET (21-Jun-2026 22:15 GMT/UTC)
Despite recent FDA approvals of amyloid-targeting antibodies, reversing Alzheimer's disease (AD) remains an ultimate challenge. A new review highlights the shift from single-target treatments to holistic strategies, integrating Tau pathology, genetics, aging, and systemic health factors to pave the way for next-generation interventions.
Brains of older adults with super healthy cognition grow more new neurons than those of their peers, according to a study from UIC, Northwestern University and the University of Washington. Researchers found that the brains of superagers — octogenarians with uncommonly nimble minds — were the most neuronally fertile, while those with Alzheimer’s disease had negligible new growth.